BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17662495)

  • 41. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
    Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
    Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing heart failure in aortic valve stenosis.
    Kupari M; Turto H; Lommi J
    J Intern Med; 2004 Nov; 256(5):381-7. PubMed ID: 15485473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population.
    Thackray SD; Witte K; Ghosh J; Nikitin N; Anderson A; Rigby A; Goode K; Clark AL; Cleland JG
    Eur Heart J; 2006 Feb; 27(4):447-53. PubMed ID: 16299020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events.
    Dhaliwal AS; Deswal A; Pritchett A; Aguilar D; Kar B; Souchek J; Bozkurt B
    J Card Fail; 2009 May; 15(4):293-9. PubMed ID: 19398076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic value of BNP for hospital mortality in elderly subjects hospitalised for acute diastolic cardiac failure].
    Arques S; Roux E; Sbragia P; Pieri B; Gélisse R; Ambrosi P
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):210-4. PubMed ID: 16618023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration.
    Gerber IL; Legget ME; West TM; Richards AM; Stewart RA
    Am J Cardiol; 2005 Apr; 95(7):898-901. PubMed ID: 15781029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A
    Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.
    Clavel MA; Malouf J; Michelena HI; Suri RM; Jaffe AS; Mahoney DW; Enriquez-Sarano M
    J Am Coll Cardiol; 2014 May; 63(19):2016-25. PubMed ID: 24657652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
    Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
    Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased B-type natriuretic peptide is associated with an abnormal blood pressure response to exercise in asymptomatic aortic stenosis.
    Van Pelt NC; Kerr AJ; Legget ME; Pasupati S; Whalley G; Wong S; Zeng I; Stewart RA
    Int J Cardiol; 2008 Jul; 127(3):313-20. PubMed ID: 18077013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
    Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.
    Ciampi Q; Borzillo G; Barbato E; Petruzziello B; Betocchi S; Villari B
    Scand Cardiovasc J; 2009 Feb; 43(1):17-23. PubMed ID: 18609042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.